相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis
Raymond Hupperts et al.
CLINICAL THERAPEUTICS (2014)
Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
Dean M. Wingerchuk et al.
MAYO CLINIC PROCEEDINGS (2014)
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis
Niklas Bergvall et al.
JOURNAL OF MEDICAL ECONOMICS (2014)
Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panel
J. Theodore Phillips et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2014)
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study
Neetu Agashivala et al.
BMC NEUROLOGY (2013)
Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence
G. Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Robert J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Comparison of adherence and persistence among multiple sclerosis patients treated with disease-modifying therapies: a retrospective administrative claims analysis
Rachel Halpern et al.
PATIENT PREFERENCE AND ADHERENCE (2011)
Factors that influence adherence with disease-modifying therapy in MS
Katherine Treadaway et al.
JOURNAL OF NEUROLOGY (2009)
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
Ludwig Kappos et al.
LANCET (2008)
Oral fingolimod (FTY720) for relapsing multiple sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
